1. Home
  2. HOTH vs OPI Comparison

HOTH vs OPI Comparison

Compare HOTH & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • OPI
  • Stock Information
  • Founded
  • HOTH 2017
  • OPI 2009
  • Country
  • HOTH United States
  • OPI United States
  • Employees
  • HOTH N/A
  • OPI N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • OPI Real Estate Investment Trusts
  • Sector
  • HOTH Health Care
  • OPI Real Estate
  • Exchange
  • HOTH Nasdaq
  • OPI Nasdaq
  • Market Cap
  • HOTH 15.6M
  • OPI 16.6M
  • IPO Year
  • HOTH 2019
  • OPI 2009
  • Fundamental
  • Price
  • HOTH $1.60
  • OPI $0.55
  • Analyst Decision
  • HOTH Strong Buy
  • OPI
  • Analyst Count
  • HOTH 3
  • OPI 0
  • Target Price
  • HOTH $4.00
  • OPI N/A
  • AVG Volume (30 Days)
  • HOTH 1.8M
  • OPI 17.7M
  • Earning Date
  • HOTH 11-11-2025
  • OPI 10-29-2025
  • Dividend Yield
  • HOTH N/A
  • OPI 5.44%
  • EPS Growth
  • HOTH N/A
  • OPI N/A
  • EPS
  • HOTH N/A
  • OPI N/A
  • Revenue
  • HOTH N/A
  • OPI $466,972,000.00
  • Revenue This Year
  • HOTH N/A
  • OPI N/A
  • Revenue Next Year
  • HOTH N/A
  • OPI N/A
  • P/E Ratio
  • HOTH N/A
  • OPI N/A
  • Revenue Growth
  • HOTH N/A
  • OPI N/A
  • 52 Week Low
  • HOTH $0.65
  • OPI $0.18
  • 52 Week High
  • HOTH $3.80
  • OPI $2.44
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 71.15
  • OPI 87.83
  • Support Level
  • HOTH $1.40
  • OPI $0.22
  • Resistance Level
  • HOTH $1.80
  • OPI $0.23
  • Average True Range (ATR)
  • HOTH 0.11
  • OPI 0.05
  • MACD
  • HOTH 0.04
  • OPI 0.03
  • Stochastic Oscillator
  • HOTH 68.75
  • OPI 61.45

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

Share on Social Networks: